Evidence map›Paper›PMID 25035086›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.

Sarah S Sanjakdar, Pretal P Maldoon, Michael J Marks, Darlene H Brunzell, Uwe Maskos, J Michael McIntosh, M Scott Bowers, M Imad Damaj

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. "Unraveling the role ofReceptors (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Genetic Architecture and Molecular Neuropathology of Human Cocaine Addiction.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  18. Article
  19. Article
  20. Cocaine potently blocks neuronal αActa pharmacologica Sinica · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sarah S SanjakdarDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Pretal P MaldoonDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Michael J MarksInstitute for Behavioral Genetics and Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA.
Darlene H BrunzellDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Uwe MaskosDépartement de Neuroscience, Institut Pasteur, Unité Neurobiologie intégrative des systèmes cholinergiques, CNRS, Paris, France.
J Michael McIntoshGeorge E. Wahlen Veterans Affairs Medical Center, and Departments of Psychiatry and Biology, University of Utah, Salt Lake City, UT, USA.
M Scott Bowers1] Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA [2] Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
M Imad DamajDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Virginia Commonwealth University · USCentre National de la Recherche Scientifique · FRUniversity of Colorado Boulder · USUniversity of Utah · US

Funding

Venoms, Biological Resources, Molecular BiologyP01GM048677 · NIGMS · UNIVERSITY OF UTAH · PI BANDYOPADHYAY, PRADIP K · 1993 to 2018
$32.2M
Center for Clinical and Translational ResearchUL1TR000058 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2012 to 2015
$12.5M
GENETICS OF NICOTINE TOLERANCE: ROLE OF RECEPTORSR01DA003194 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 1985 to 2013
$5.5M
Studies with Nicotinic Null Mutant MiceP30DA015663 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 2003 to 2013
$4.5M
Synthesis of Bupropion Analogs, Including Possible Metabolites and 3-PhenyltropanU19DA019377 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI DAMAJ, M. IMAD · 2005 to 2009
$3.4M
Novel nAChR-Targeted PeptidesR01GM103801 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2012 to 2019
$2.4M
Genes and molecular pathways in nicotine dependence and withdrawalR01DA032246 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD, MILES, MICHAEL F · 2013 to 2017
$1.7M
Nicotinic contributions to affective behaviorR01DA031289 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BRUNZELL, DARLENE H · 2011 to 2015
$1.6M
Role of calcium-dependent mechanisms in nicotine's tolerance and effectsR01DA012610 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD · 2001 to 2010
$1.6M
NCATS NIH HHS UL1 TR000058NIDA NIH HHS DA003194NIDA NIH HHS DA-019377NIDA NIH HHS P30 DA15663NIDA NIH HHS R01 DA012610NIDA NIH HHS R01 DA031289NIDA NIH HHS R01 DA032246NIGMS NIH HHS GM103801NIGMS NIH HHS GM48677
6 · The paper itself

Abstract

Mesolimbic α6* nicotinic acetylcholine receptors (nAChRs) are thought to have an important role in nicotine behavioral effects. However, little is known about the role of the various α6*-nAChRs subtypes in the rewarding effects of nicotine. In this report, we investigated and compared the role of α6*-nAChRs subtypes and their neuro-anatomical locus in nicotine and cocaine reward-like effects in the conditioned place preference (CPP) paradigm, using pharmacological antagonism of α6β2* nAChRs and genetic deletion of the α6 or α4 subunits in mice. We found that α6 KO mice exhibited a rightward shift in the nicotine dose-response curve compared with WT littermates but that α4 KO failed to show nicotine preference, suggesting that α6α4β2*-nAChRs are involved. Furthermore, α6β2* nAChRs in nucleus accumbens were found to have an important role in nicotine-conditioned reward as the intra-accumbal injection of the selective α6β2* α-conotoxin MII [H9A; L15A], blocked nicotine CPP. In contrast to nicotine, α6 KO failed to condition to cocaine, but cocaine CPP in the α4 KO was preserved. Intriguingly, α-conotoxin MII [H9A; L15A], blocked cocaine conditioning in α4 KO mice, implicating α6β2* nAChRs in cocaine reward. Importantly, these effects did not generalize as α6 KO showed both a conditioned place aversion to lithium chloride as well as CPP to palatable food. Finally, dopamine uptake was not different between the α6 KO or WT mice. These data illustrate that the subjective rewarding effects of both nicotine and cocaine may be mediated by mesolimbic α6β2* nAChRs and that antagonists of these receptor subtypes may exhibit therapeutic potential.

Indexed as

AnimalsAvoidance LearningCocaineConditioning, PsychologicalConotoxinsDopamineDopamine Uptake InhibitorsDose-Response Relationship, DrugFoodLithium ChlorideMaleMice, Inbred C57BLMice, KnockoutNeuronsNicotineNicotinic Agonistsalpha6beta2 nicotinic acetylcholine receptoralpha-conotoxin MIICocaineConotoxinsDopamineDopamine Uptake InhibitorsLithium ChlorideNicotineNicotinic AgonistsNicotinic Antagonistsnicotinic receptor alpha4beta2Receptors, Nicotinic

Identifiers

PMID25035086
PMCPMC4443947
OpenAlexW2312442692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.